Tessera Defense and Homeland Security(HLSQ)
$0.02-0.00 (-16.67%)
HLSQ
Tessera Defense and Homeland Security stock drug pipeline
$0.02
At close:-0.00 (-16.67%)
Want to see HLSQ full AI Analyst Report?
Tessera Defense and Homeland Security (HLSQ) Drug Pipeline
928 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bx004 | Cystic Fibrosis (Cf), Chronic Pseudomonas Aeruginosa Infection | Phase II | Recruiting | Study With Phage for CF Subjects With Pseudomonas Lung Infection | May 10, 2025 | ― |
| Bx005-A | Atopic Dermatitis | phase1AndPhase2 | Withdrawn | A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis | Jan 23, 2022 | ― |
| Bx004-A | Cystic Fibrosis, Chronic Pseudomonas Aeruginosa Infection | phase1AndPhase2 | Completed | Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection | Aug 11, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bx004 | Phase II | Cystic Fibrosis (Cf), Chronic Pseudomonas Aeruginosa Infection | Recruiting | Study With Phage for CF Subjects With Pseudomonas Lung Infection | May 10, 2025 | ― |
| Bx005-A | phase1AndPhase2 | Atopic Dermatitis | Withdrawn | A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis | Jan 23, 2022 | ― |
| Bx004-A | phase1AndPhase2 | Cystic Fibrosis, Chronic Pseudomonas Aeruginosa Infection | Completed | Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection | Aug 11, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tessera Defense And Homeland Security Inc. (HLSQ) have in its pipeline
Tessera Defense and Homeland Security HLSQ is currently developing the following drugs: Bx004, Bx005-A, Bx004-A. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

